Renaissance Technologies
COCP icon

Renaissance Technologies’s Cocrystal Pharma COCP Stock Holding History

Renaissance Technologies’s Portfolio COCP Stock Details COCP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$201K Sell
174,998
-4,630
-3% -$4.95K ﹤0.01% 2899
2026
Q2 		$189K Buy
179,628
+55,700
+45% +$68.5K ﹤0.01% 2891
2026
Q1 		$125K Sell
123,928
-2,100
-2% -$2.17K ﹤0.01% 2993
2025
Q4 		$123K Sell
126,028
-1,900
-1% -$2.01K ﹤0.01% 2972
2025
Q3 		$160K Buy
127,928
+2,900
+2% +$4.48K ﹤0.01% 3180
2025
Q2 		$186K Sell
125,028
-600
-0.5% -$893 ﹤0.01% 3186
2025
Q1 		$178K Sell
125,628
-200
-0.2% -$373 ﹤0.01% 3097
2024
Q4 		$254K Sell
125,828
-4,200
-3% -$8.4K ﹤0.01% 3090
2024
Q3 		$229K Buy
130,028
+200
+0.2% +$389 ﹤0.01% 3079
2024
Q2 		$302K Buy
129,828
+3,800
+3% +$7.41K ﹤0.01% 2903
2024
Q1 		$176K Buy
126,028
+900
+0.7% +$1.4K ﹤0.01% 3253
2023
Q4 		$215K Sell
125,128
-1,100
-0.9% -$1.96K ﹤0.01% 3110
2023
Q3 		$236K Buy
126,228
+1,700
+1% +$4.27K ﹤0.01% 3032
2023
Q2 		$298K Buy
124,528
+4,700
+4% +$11.4K ﹤0.01% 3123
2023
Q1 		$238K Buy
119,828
+5,800
+5% +$13K ﹤0.01% 3208
2022
Q4 		$222K Sell
114,028
-19,674
-15% -$50.4K ﹤0.01% 3370
2022
Q3 		$467K Sell
133,702
-8,151
-6% -$38.2K ﹤0.01% 2962
2022
Q2 		$698K Sell
141,853
-174
-0.1% -$927 ﹤0.01% 2945
2022
Q1 		$937K Sell
142,027
-16,550
-10% -$110K ﹤0.01% 2771
2021
Q4 		$1.24M Sell
158,577
-10,320
-6% -$106K ﹤0.01% 2495
2021
Q3 		$2.13M Sell
168,897
-47,264
-22% -$625K ﹤0.01% 2040
2021
Q2 		$3.24M Sell
216,161
-138,412
-39% -$2.1M ﹤0.01% 1918
2021
Q1 		$5.91M Buy
354,573
+25,408
+8% +$516K 0.01% 1554
2020
Q4 		$5.37M Buy
329,165
+10,467
+3% +$145K 0.01% 1539
2020
Q3 		$3.56M Buy
318,698
+62,754
+25% +$1.15M ﹤0.01% 1774
2020
Q2 		$4.67M Buy
255,944
+128,992
+102% +$1.58M ﹤0.01% 1684
2020
Q1 		$1.08M Buy
126,952
+116,179
+1,078% +$1.09M ﹤0.01% 2388
2019
Q4 		$64K Buy
10,773
+9,896
+1,128% +$98.8K ﹤0.01% 3369
2019
Q3 		$22K Buy
+877
New +$22.7K ﹤0.01% 3371

Other funds holding COCP

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Parallel Advisors
Parallel Advisors San Francisco, California $7.42B AUM 27.68% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Clean Yield Group
Clean Yield Group Norwich, Vermont $412M AUM 20.54% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
NVWM LLC
NVWM LLC Yardley, Pennsylvania $533M AUM 27.53% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Renaissance Technologies's COCP Position: Q3 2026 in Review

Renaissance Technologies reduced its Cocrystal Pharma (COCP) stake by 2.6% in Q3 2026, selling an estimated $4.95K and leaving 174,998 shares worth $201K. The position accounts for ﹤0.01% of the portfolio, ranked #2899.

Renaissance Technologies first reported a position in COCP in Q3 2019 and has held it in 29 quarters since. The position peaked at $5.91M in Q1 2021. 14 funds tracked by Wall St. Rank hold COCP as of Q3 2026.

  • Renaissance Technologies held 174,998 shares of Cocrystal Pharma worth $201K as of Q3 2026.
  • Renaissance Technologies sold 4,630 Cocrystal Pharma shares in Q3 2026, an estimated $4.95K.
  • Cocrystal Pharma made up ﹤0.01% of Renaissance Technologies's portfolio in Q3 2026, its #2899 holding.
  • Renaissance Technologies first reported a position in Cocrystal Pharma in Q3 2019 and has held it in 29 quarters since.
  • Renaissance Technologies's Cocrystal Pharma position peaked at $5.91M in Q1 2021.
  • 14 funds tracked by Wall St. Rank held Cocrystal Pharma as of Q3 2026.

Based on Renaissance Technologies's 13F filing for Q3 2026, filed 12 Nov 2026.